Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates [Yahoo! Finance]
Axsome Therapeutics, Inc. (AXSM)
Last axsome therapeutics, inc. earnings: 3/12 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
axsome.com
Company Research
Source: Yahoo! Finance
The Zacks Consensus Estimate was pegged at a loss of $1.20 per share. The above-adjusted loss excludes the impact of certain non-cash charges, including which the reported loss per share was $1.44 in the first quarter of 2024 compared with a loss of 26 cents per share reported in the year-ago quarter. The company reported total revenues of $75 million for the first quarter, which beat the Zacks Consensus Estimate of $70 million. AXSM had recorded revenues of $94.6 million in the year-ago period. The year-over-year decline in revenues can be attributed to a one-time upfront payment received for the out-licensing of Sunosi in certain ex-U.S. markets in the year-ago quarter. Shares of Axsome have decreased 4.6% so far this year compared with the industry's decline of 5.8%. Image Source: Zacks Investment Research Quarter in Detail Total revenues in the first quarter consisted of product revenues from Sunosi and Auvelity, and royalty revenues. Net product revenues were $74.1
Show less
Read more
Impact Snapshot
Event Time:
AXSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AXSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AXSM alerts
High impacting Axsome Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AXSM
News
- Prediction: These 2 Growth Stocks Could Triple By 2030 [Yahoo! Finance]Yahoo! Finance
- Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year [Yahoo! Finance]Yahoo! Finance
- Axsome Therapeutics, Inc. (NASDAQ: AXSM) had its price target lowered by analysts at Mizuho from $109.00 to $106.00. They now have a "buy" rating on the stock.MarketBeat
- Axsome Therapeutics to Present at Upcoming Investor Conferences [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Axsome Therapeutics to Present at Upcoming Investor ConferencesGlobeNewswire
AXSM
Earnings
- 5/6/24 - Miss
AXSM
Sec Filings
- 5/6/24 - Form 10-Q
- 5/6/24 - Form 8-K
- 4/26/24 - Form ARS
- AXSM's page on the SEC website